StockData
Replimune Group, Inc. logo

Replimune Group, Inc. (REPL) stock

REPLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends March 31
Số liệu tài chính tới Q2 năm tài chính 2027, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q/A on Nov 6, 2026Score 1/30
$19.69−1.72 (-8.03%)

Close on Nov 17, 2026Market cap $1.87BP/E –Yield –

Replimune revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2019CQ4 2018Dec 31, 2018$0–
Q2 FY2019CQ3 2018Sep 30, 2018$0–
Q1 FY2019CQ2 2018Jun 30, 2018$0–

More Replimune figures

See a number that looks wrong?